Australia has a tough, newly validated weapon to go after multinational companies it sees as tax dodgers—and US technology and pharmaceutical companies may take a hit.
A recent court ruling against
Australia has a tough, newly validated weapon to go after multinational companies it sees as tax dodgers—and US technology and pharmaceutical companies may take a hit.
A recent court ruling against